Sign in
4

Changes in Ownership

Corbus Pharmaceuticals Holdings, Inc. Filed Acc 0001209191-20-019931

Chief Operating Officer bought 2,840 shares at $3.54 ($10,054)

From the SEC's structured data for this filing

Trades in this filing

Discordia Robert Paul · Chief Operating Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2020-03-17 Purchase : show line 1 in the form +2,840 $3.54 $10,054 35,490 D
Open-market purchases · 2,840 sh · avg $3.54 · $10,054
Loading xslF345X03/doc4.xml…